AMNEAL PHARMACEUTICALS INC (AMRX) Stock Price, Quote, News and Overview
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
AMRX Quote, Performance and Key Statistics
NASDAQ:AMRX (6/4/2025, 12:22:35 PM)
7.405
-0.04 (-0.6%)
The current stock price of AMRX is 7.405 USD. In the past month the price decreased by -1.19%. In the past year, price increased by 10.37%.
AMRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 55.78 | 727.39B | ||
| JNJ | JOHNSON & JOHNSON | 15.28 | 369.39B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 20.29 | 323.66B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.15 | 232.17B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.65 | 227.10B | ||
| MRK | MERCK & CO. INC. | 10.12 | 197.99B | ||
| PFE | PFIZER INC | 7.3 | 133.29B | ||
| SNY | SANOFI-ADR | 11.18 | 120.82B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.58 | 98.22B | ||
| GSK | GSK PLC-SPON ADR | 9.2 | 82.91B | ||
| ZTS | ZOETIS INC | 28.22 | 75.63B | ||
| HLN | HALEON PLC-ADR | 22.4 | 49.41B |
Related stock screener links
About AMRX
Company Profile
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. The company is headquartered in Bridgewater, New Jersey and currently employs 8,100 full-time employees. The company went IPO on 2009-11-18. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Company Info
AMNEAL PHARMACEUTICALS INC
400 Crossing Boulevard, 3rd Floor
Bridgewater NEW JERSEY 08807 US
CEO: Chirag Patel
Employees: 8300
Phone: 19089473120
AMNEAL PHARMACEUTICALS INC / AMRX FAQ
What is the stock price of AMNEAL PHARMACEUTICALS INC today?
The current stock price of AMRX is 7.405 USD. The price decreased by -0.6% in the last trading session.
What is the ticker symbol for AMNEAL PHARMACEUTICALS INC stock?
The exchange symbol of AMNEAL PHARMACEUTICALS INC is AMRX and it is listed on the Nasdaq exchange.
On which exchange is AMRX stock listed?
AMRX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AMNEAL PHARMACEUTICALS INC stock?
9 analysts have analysed AMRX and the average price target is 11.73 USD. This implies a price increase of 58.41% is expected in the next year compared to the current price of 7.405. Check the AMNEAL PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMNEAL PHARMACEUTICALS INC worth?
AMNEAL PHARMACEUTICALS INC (AMRX) has a market capitalization of 2.32B USD. This makes AMRX a Mid Cap stock.
How many employees does AMNEAL PHARMACEUTICALS INC have?
AMNEAL PHARMACEUTICALS INC (AMRX) currently has 8300 employees.
What are the support and resistance levels for AMNEAL PHARMACEUTICALS INC (AMRX) stock?
AMNEAL PHARMACEUTICALS INC (AMRX) has a support level at 7.37 and a resistance level at 7.98. Check the full technical report for a detailed analysis of AMRX support and resistance levels.
Is AMNEAL PHARMACEUTICALS INC (AMRX) expected to grow?
The Revenue of AMNEAL PHARMACEUTICALS INC (AMRX) is expected to grow by 8.95% in the next year. Check the estimates tab for more information on the AMRX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AMNEAL PHARMACEUTICALS INC (AMRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMRX, evaluating the profitability, health, valuation and growth aspects
- AMNEAL PHARMACEUTICALS INC (AMRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMNEAL PHARMACEUTICALS INC (AMRX) Sales and EPS estimates to see what analysts future expectations are.
- AMNEAL PHARMACEUTICALS INC (AMRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMNEAL PHARMACEUTICALS INC (AMRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMNEAL PHARMACEUTICALS INC (AMRX) Stock Chart to make your own analysis
- AMNEAL PHARMACEUTICALS INC (AMRX) Latest news and press-releases to stay up to date.
Does AMNEAL PHARMACEUTICALS INC (AMRX) stock pay dividends?
AMRX does not pay a dividend.
When does AMNEAL PHARMACEUTICALS INC (AMRX) report earnings?
AMNEAL PHARMACEUTICALS INC (AMRX) will report earnings on 2025-08-08, before the market open.
What is the Price/Earnings (PE) ratio of AMNEAL PHARMACEUTICALS INC (AMRX)?
The PE ratio for AMNEAL PHARMACEUTICALS INC (AMRX) is 11.39. This is based on the reported non-GAAP earnings per share of 0.65 and the current share price of 7.405 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMRX.
What is the Short Interest ratio of AMNEAL PHARMACEUTICALS INC (AMRX) stock?
The outstanding short interest for AMNEAL PHARMACEUTICALS INC (AMRX) is 3.47% of its float. Check the ownership tab for more information on the AMRX short interest.
AMRX Technical Analysis
AMRX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AMRX. AMRX has a medium profitability rating, but doesn't score so well on its financial health evaluation.
AMRX Financial Highlights
Over the last trailing twelve months AMRX reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS decreased by -1.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.39% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AMRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to AMRX. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 21.34% and a revenue growth 8.95% for AMRX